April 12, 2022 - Comments Off on Omega Ophthalmics CMO, Gary Wortz, MD Named on The Ophthalmologist’s 2022 Power List

Omega Ophthalmics CMO, Gary Wortz, MD Named on The Ophthalmologist’s 2022 Power List

New York, US, April 07, 2022 – After thousands of votes were received and the final list of nominees was scrutinized by an eminent panel of judges, Gary Wortz, MD has been selected to feature on the prestigious Power List from The Ophthalmologist, a leading publication in the field. For 2022, the list highlights the Top 100 most influential people in the world of ophthalmology, including the giants of clinical practice and vision research as well as up and coming talent, too.

Editors of The Ophthalmologist launched The Power List in 2014 to acknowledge and recognize those making waves in the field of ophthalmology – and beyond. Thousands of nominations were received from loyal readers of the publication, with the finalists chosen from a list of more than 450 names by an international panel of 20 judges. These annual awards have proven to be one of the most anticipated issues among readers year on year.

Aleksandra Jones, Editor of The Ophthalmologist, says, “Putting the annual Power List together is the highlight of my year! It is wonderful to see how much this honor means to the people selected for the list, and it’s a great opportunity to celebrate ophthalmology – one of the most forward-thinking fields of clinical practice and research.”

See The Ophthalmologist’s Power List 2022 here.

About The Ophthalmologist
The Ophthalmologist is a leading publication for professionals in all areas of ophthalmic clinical practice. Through its resources – website, newsletters, webinars, social channels, monthly print magazine and video – The Ophthalmologist gives its vast audience of readers a truly global and multimedia platform from which to learn, communicate, network and further the field of ophthalmology.

Published by: Omega Ophthalmics in Company News

September 13, 2016 - Comments Off on Omega Ophthalmics Receives Issuance of 2nd Continuation Alpha Patent from USPTO

Omega Ophthalmics Receives Issuance of 2nd Continuation Alpha Patent from USPTO

Lexington, KY – September 13, 2016

Omega Ophthalmics is pleased to announce that a 2nd continuation for its Alpha Family of patents has been issued by the United States Patent and Trademark Office.

This continuation is for invention number 9,439,754, a patent for a “prosthetic capsular bag and method of inserting the same."

Read more

Published by: Omega Ophthalmics in Company News, Intellectual Property, Press Releases

August 16, 2016 - Comments Off on Omega Ophthalmics Receives Issuance of 1st Continuation Bravo Patent from USPTO

Omega Ophthalmics Receives Issuance of 1st Continuation Bravo Patent from USPTO

Lexington, KY – August 16, 2016

Omega Ophthalmics is pleased to announce that a continuation for Prosthetic Capsular Devices, Systems, and Methods has been issued by the United States Patent & Trademark Office (USPTO).

The patent for invention number 9,414,907 is for a “Prosthetic Capsular Devices, Systems, and Methods,” and contains protections surrounding "wearable technology that provides biometric data, such as blood glucose levels, body temperature, electrolyte balance, heart rate...and the like that can assist in technology-assisted health care functions."

Read more

Published by: Omega Ophthalmics in Company News, Intellectual Property, Press Releases

June 7, 2016 - Comments Off on Omega Ophthalmics Issued Patent for Prosthetic Capsular Devices, Systems, and Methods by USPTO

Omega Ophthalmics Issued Patent for Prosthetic Capsular Devices, Systems, and Methods by USPTO

Lexington, KY – June 7, 2015

Omega Ophthalmics is pleased to announce that a patent for Prosthetic Capsular Devices, Systems, and Methods has been issued by the United States Patent & Trademark Office (USPTO).

The patent for invention number 9,358,103 is for a “Prosthetic Capsular Devices, Systems, and Methods,” and contains protections surrounding methods for inserting high-technology devices inside the eye.

Read more

Published by: Omega Ophthalmics in Company News, Intellectual Property, Press Releases

December 21, 2015 - Comments Off on Omega Ophthalmics Receives Successful Animal Study Results

Omega Ophthalmics Receives Successful Animal Study Results

Lexington, KY – December 21, 2015

Omega Ophthalmics is pleased to announce the successful results of its animal study for a prosthetic capsular bag.

The animal study was performed by Drs. Nick Mamalis and Lilliana Werner at the University of Utah. The study, which lasted four weeks, was designed to prove form and fit in rabbit eyes using the latest prototype of the Omega device.

Read more

Published by: Omega Ophthalmics in Company News, Press Releases